Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Leyland-Jones

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Seminars in Oncology|May 31, 2003
Treatment of cancer-related hypercalcemia: the role of gallium nitrateBrian Leyland-Jones
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
The safety of erythropoiesis-stimulating agents in cancer patientsBrian Leyland-Jones
Seminars in Oncology|July 26, 2002
Evidence for erythropoietin as a molecular targeting agentBrian Leyland-Jones
The Lancet. Oncology|August 7, 2003
Breast cancer trial with erythropoietin terminated unexpectedlyBrian Leyland-Jones,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastasesBrian Leyland-Jones
The Journal of Supportive Oncology|December 21, 2004
Treating cancer-related hypercalcemia with gallium nitrateBrian Leyland-Jones
The Lancet. Oncology|March 21, 2002
Trastuzumab: hopes and realitiesBrian Leyland-Jones
Journal of the National Cancer Institute|July 18, 2013
Erythropoiesis stimulating agents: a personal journeyBrian Leyland-Jones
Cancer Genomics & Proteomics|September 20, 2007
Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatmentMark Abramovitz, Brian Leyland-Jones
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerBrian Leyland-Jones, Salaheddin Mahmud
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Seminars in Oncology|May 31, 2003
Treatment of cancer-related hypercalcemia: the role of gallium nitrateBrian Leyland-Jones
Clinical Advances in Hematology & Oncology : H&O|February 13, 2014
The safety of erythropoiesis-stimulating agents in cancer patientsBrian Leyland-Jones
Seminars in Oncology|July 26, 2002
Evidence for erythropoietin as a molecular targeting agentBrian Leyland-Jones
The Lancet. Oncology|August 7, 2003
Breast cancer trial with erythropoietin terminated unexpectedlyBrian Leyland-Jones,
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastasesBrian Leyland-Jones
The Journal of Supportive Oncology|December 21, 2004
Treating cancer-related hypercalcemia with gallium nitrateBrian Leyland-Jones
The Lancet. Oncology|March 21, 2002
Trastuzumab: hopes and realitiesBrian Leyland-Jones
Journal of the National Cancer Institute|July 18, 2013
Erythropoiesis stimulating agents: a personal journeyBrian Leyland-Jones
Cancer Genomics & Proteomics|September 20, 2007
Application of array-based genomic and epigenomic technologies to unraveling the heterogeneous nature of breast tumors: on the road to individualized treatmentMark Abramovitz, Brian Leyland-Jones
Lancet (London, England)|January 16, 2004
Erythropoietin to treat anaemia in patients with head and neck cancerBrian Leyland-Jones, Salaheddin Mahmud
Pageof 11